Open access
Jul 2026
Exploring the Breast Cancer Inhibitor from Flavone Subclass: In Silico and In Vitro Assays
It is suggested that amentoflavone has potential as a natural lead compound for further optimization and development of ERα-targeted therapies in ER-positive breast cancer.
D. S. F. Ramadhan, Nurisyah Nurisyah, Asyhari Asyikin et al.
· Indonesian Journal of Chemis... · 0 citations